Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.20.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Operating revenues:    
License revenues $ 500
Operating expenses:    
Research and development 7,900 4,522
General and administrative 3,693 2,739
Total operating expenses 11,593 7,261
Operating loss (11,593) (6,761)
Other (income) expense:    
Governmental assistance - research incentives (856) (1,214)
Other (income) expense, net (119) 68
Change in fair value of warrant liability 39
Total other income, net (975) (1,107)
Loss before income tax expense (10,618) (5,654)
Income tax expense 31 80
Net loss (10,649) (5,734)
Other comprehensive income    
Unrealized gain on marketable securities (2)
Net loss and comprehensive loss $ (10,647) $ (5,734)
Basic and diluted net loss per share (in dollars per share) $ (0.89) $ (0.74)
Weighted average shares outstanding – basic and diluted (in shares) 11,987,696 7,743,520